Here's the live share price of Phaarmasia along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Phaarmasia has gained 6.96% CAGR. Over the past year, the corresponding return has been -39.84%.
Phaarmasia’s current P/E of -16.47x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Phaarmasia | 15.06 | 38.89 | 16.63 | 20.80 | -39.84 | 14.27 | 6.96 |
Sun Pharmaceutical Industries | 0.99 | -1.32 | -4.43 | -5.58 | -13.53 | 22.86 | 25.44 |
Divi's Laboratories | 1.35 | -1.39 | -9.09 | 7.26 | 10.98 | 19.38 | 13.39 |
Cipla | 0.28 | -0.53 | 1.92 | 4.23 | -6.24 | 14.18 | 15.63 |
Torrent Pharmaceuticals | -2.95 | -3.25 | 7.81 | 15.50 | 2.38 | 33.75 | 19.96 |
Dr. Reddy's Laboratories | 1.28 | 3.65 | -2.73 | 13.87 | -1.48 | 17.07 | 7.18 |
Mankind Pharma | -0.83 | 3.97 | 8.45 | 18.23 | 4.55 | 21.72 | 12.52 |
Zydus Lifesciences | -0.29 | 4.77 | 6.12 | 15.71 | -7.35 | 42.05 | 21.62 |
Lupin | 4.71 | 4.15 | 2.02 | 3.02 | -8.93 | 48.04 | 14.81 |
Abbott India | 1.23 | -4.93 | -2.02 | 2.81 | 6.44 | 20.90 | 13.41 |
Alkem Laboratories | 3.35 | 3.02 | 13.21 | 14.40 | -13.33 | 20.01 | 14.29 |
Aurobindo Pharma | 4.59 | 0.18 | -4.54 | -1.88 | -30.10 | 26.95 | 5.60 |
Glenmark Pharmaceuticals | -1.88 | 5.17 | 23.41 | 45.12 | 19.22 | 77.31 | 32.95 |
Laurus Labs | -0.75 | 3.48 | 31.71 | 54.01 | 77.48 | 20.12 | 27.15 |
Biocon | -1.28 | -1.15 | 0.76 | 7.82 | -7.87 | 7.34 | -3.86 |
Anthem Biosciences | 2.21 | 4.53 | 14.60 | 14.60 | 14.60 | 4.65 | 2.76 |
GlaxoSmithKline Pharmaceuticals | -2.60 | -1.60 | -18.46 | 1.95 | -3.00 | 24.23 | 9.16 |
Cohance Lifesciences | -2.90 | 10.08 | -0.45 | -12.87 | -15.54 | 28.96 | 21.52 |
Ipca Laboratories | -0.61 | -5.32 | -3.76 | -0.34 | -10.15 | 14.97 | 3.52 |
Gland Pharma | 5.03 | 2.24 | 13.95 | 29.79 | 8.06 | -4.20 | 2.06 |
Over the last one year, Phaarmasia has declined 39.84% compared to peers like Sun Pharmaceutical Industries (-13.53%), Divi's Laboratories (10.98%), Cipla (-6.24%). From a 5 year perspective, Phaarmasia has underperformed peers relative to Sun Pharmaceutical Industries (25.44%) and Divi's Laboratories (13.39%).
Day | SMA | EMA |
---|---|---|
5 | 33.61 | 34.75 |
10 | 33.15 | 33.64 |
20 | 30.95 | 32.55 |
50 | 32.4 | 31.99 |
100 | 31.08 | 32.82 |
200 | 36.98 | 35.47 |
In the latest quarter, Phaarmasia remained same as its previous close in promoter holding, while DII stake unchanged at 0.05%, FII holding unchanged at 0.00%, and public shareholding moved down to 26.42% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 11, 2025, 3:28 AM IST | Phaarmasia Ltd. - Announcement under Regulation 30 (LODR)-Restructuring |
Sep 03, 2025, 7:44 PM IST | Phaarmasia Ltd. - Intimation Of 44Th Annual General Meeting Of Phaarmasia Limited And Remote E-Voting. |
Sep 03, 2025, 7:37 PM IST | Phaarmasia Ltd. - Reg. 34 (1) Annual Report. |
Aug 13, 2025, 6:23 AM IST | Phaarmasia Ltd. - Integrated Filing (Financials) For The Quarter Ended 30Th June, 2025 |
Aug 11, 2025, 10:33 PM IST | Phaarmasia Ltd. - Financial Results For The Quarter Ended 30Th June 2025 - Regulation 33(3) (A) Of SEBI (LODR) Regulations, 2 |
Phaarmasia Ltd. is a Public Limited Listed company incorporated on 06/02/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1981PLC002915 and registration number is 002915. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 24.37 Cr. and Equity Capital is Rs. 6.83 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Phaarmasia is ₹38.50 as on Sep 16, 2025.
The Phaarmasia is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Phaarmasia is ₹26.28 Cr as on Sep 16, 2025.
Today’s highest and lowest price of Phaarmasia are ₹39.50 and ₹35.92.
The 52-week high/low is the highest and lowest price at which Phaarmasia stock has traded in the past 52-week or nearly a year. The 52-week high of Phaarmasia is ₹64.53 and 52-week low of Phaarmasia is ₹23.60 as on Sep 16, 2025.
The Phaarmasia has shown returns of 1.85% over the past day, 38.89% for the past month, 16.63% over 3 months, -39.84% over 1 year, 14.27% across 3 years, and 6.96% over 5 years.
P/E ratio of and PB ratio of Phaarmasia are -16.47 and 3.01 on Sep 16, 2025. While the company gives a dividend yield of 0.00 per annum.